dexniguldipine

This page covers all dexniguldipine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine receptor A3, Multidrug resistance protein 1, Alpha-1A adrenergic receptor.

Targets

Adenosine receptor A3, Multidrug resistance protein 1, Alpha-1A adrenergic receptor

Phase 2 pipeline (1)

• Niguldipine Fumarate · Hematology
  DEXNIGULDIPINE works by selectively blocking the Alpha-1A adrenergic receptor, which helps to regulate blood vessel constriction and blood pressure.

Patent intelligence

• dexniguldipine patent landscape — aggregated cliff calendar, attackable patents, originator estates